Literature DB >> 33716751

Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1α, and Hsp70: Implication of Altered Regulation of Cell Survival, pH Homeostasis, Mitochondrial Functions.

Yugal Goel1, Saveg Yadav1, Shrish Kumar Pandey1, Mithlesh Kumar Temre1, Vinay Kumar Singh2, Ajay Kumar3, Sukh Mahendra Singh1.   

Abstract

Methyl jasmonate (MJ) displays antineoplastic potential against numerous neoplastic cells. However, several mechanistic aspects of its antineoplastic action against malignancies of T cell origin remain elusive. The present investigation reports the novel targets of MJ and mechanistic pathways of MJ-mediated antineoplastic and chemosensitizing action against tumor cells derived from murine T-cell lymphoma, designated as Dalton's lymphoma (DL). The present study demonstrates that MJ directly docks to HIF-1α, hexokinase 2, and Hsp70 at prominent binding sites. MJ exhibits tumoricidal action against tumor cells via induction of apoptosis and necrosis through multiple pathways, including declined mitochondrial membrane potential, enhanced expression of ROS, altered pH homeostasis, an elevated level of cytosolic cytochrome c, and modulated expression of crucial cell survival and metabolism regulatory molecules. Additionally, this study also reports the chemosensitizing ability of MJ against T cell lymphoma accompanied by a declined expression of MDR1. This study sheds new light by demonstrating the implication of novel molecular mechanisms underlying the antitumor action of MJ against T-cell lymphoma and hence has immense translational significance.
Copyright © 2021 Goel, Yadav, Pandey, Temre, Singh, Kumar and Singh.

Entities:  

Keywords:  chemosensitivitiy; metabolism; methyl jasmonate; pH homeostasis; tumor cytotoxicity

Year:  2021        PMID: 33716751      PMCID: PMC7954117          DOI: 10.3389/fphar.2021.628329

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  55 in total

Review 1.  Bioinformatics Approaches for Anti-cancer Drug Discovery.

Authors:  Kening Li; Yuxin Du; Lu Li; Dong-Qing Wei
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

2.  Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death.

Authors:  Saveg Yadav; Praveen Kumar Kujur; Shrish Kumar Pandey; Yugal Goel; Babu Nandan Maurya; Ashish Verma; Ajay Kumar; Rana Pratap Singh; Sukh Mahendra Singh
Journal:  Toxicol Appl Pharmacol       Date:  2017-12-05       Impact factor: 4.219

3.  α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton's lymphoma cells: role of altered cell survival-regulatory mechanisms.

Authors:  Ajay Kumar; Shiva Kant; Sukh Mahendra Singh
Journal:  Anticancer Drugs       Date:  2013-02       Impact factor: 2.248

4.  Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines.

Authors:  A Gewies; O W Rokhlin; M B Cohen
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

5.  Methyl jasmonate binds to and detaches mitochondria-bound hexokinase.

Authors:  N Goldin; L Arzoine; A Heyfets; A Israelson; Z Zaslavsky; T Bravman; V Bronner; A Notcovich; V Shoshan-Barmatz; E Flescher
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

6.  Visualization of mitochondrial membrane potential in mammalian cells.

Authors:  Noemí Esteras; Merel J W Adjobo-Hermans; Andrey Y Abramov; Werner J H Koopman
Journal:  Methods Cell Biol       Date:  2019-12-10       Impact factor: 1.441

7.  Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice.

Authors:  Jingjing Li; Kan Chen; Fan Wang; Weiqi Dai; Sainan Li; Jiao Feng; Liwei Wu; Tong Liu; Shizan Xu; Yujing Xia; Jie Lu; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  Oncotarget       Date:  2017-07-11

8.  Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies.

Authors:  Saveg Yadav; Shrish Kumar Pandey; Vinay Kumar Singh; Yugal Goel; Ajay Kumar; Sukh Mahendra Singh
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

9.  T-cell lymphomas in South america and europe.

Authors:  Monica Bellei; Carlos Sergio Chiattone; Stefano Luminari; Emanuela Anna Pesce; Maria Elena Cabrera; Carmino Antonio de Souza; Raul Gabús; Lucia Zoppegno; Lucia Zoppegno; Jorge Milone; Astrid Pavlovsky; Joseph Michael Connors; Francine Mary Foss; Steven Michael Horwitz; Raymond Liang; Silvia Montoto; Stefano Aldo Pileri; Aaron Polliack; Julie Marie Vose; Pier Luigi Zinzani; Emanuele Zucca; Massimo Federico
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism.

Authors:  Jitka Soukupova; Andrea Malfettone; Petra Hyroššová; María-Isabel Hernández-Alvarez; Irene Peñuelas-Haro; Esther Bertran; Alexandra Junza; Jordi Capellades; Gianluigi Giannelli; Oscar Yanes; Antonio Zorzano; José Carlos Perales; Isabel Fabregat
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

View more
  1 in total

1.  Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity.

Authors:  Mithlesh Kumar Temre; Saveg Yadav; Yugal Goel; Shrish Kumar Pandey; Ajay Kumar; Sukh Mahendra Singh
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.